The registration of the 6 CANNANSEN® CBD medicinal products with the MHRA enables CS MEDICA to market and sell their 6 CANNANSEN® CBD medicinal products in the UK. The registration has further significance for the company's efforts to achieve brand awareness globally.

"The registration at the MHRA in the UK  is an important step for CS MEDICA as the UK works as a display market for Australia, MENA (Middle East and North Africa) and other countries where the local health authorities use the UK as a reference country. Hence the MHRA registration is an significant mark in our efforts to create global awareness and sale," Lone Henriksen, CEO CS MEDICA comments.

For more information about CS MEDICA, please contact:
Lone Henriksen, CEO
Phone: + (45) 71 20 30 47
Email: lh@cs-medica.com
Website: https://www.cs-medica.com/

CS MEDICA A/S is a Danish medico cannabis company founded in 2011. CS MEDICA is committed to developing, manufacturing, and commercializing over-the-counter (OTC) medical device products containing cannabinoids. The Company runs its business through the two fully-owned subsidiaries, Galaxa Pharma A/S (distributor and representative of foreign manufacturers in the Nordic, registered medical device product distributor) and CanNordic A/S (Medical device developer and seller (BtB), registered medical device product manufacturer). CS MEDICA distributes products across the European borders and is headquartered in Copenhagen, Denmark.

The company is listed on Spotlight Stock Market in Stockholm (symbol: "CSMED"). For more information about CS MEDICA cs-medica.com.